Dr. Jeffrey Abraham Bander, MD

Dr. Bander practices at Cardio Vascular Institute of Mount Sinai in Brooklyn, New York.

Dr. Bander's NPI, 1649438672, was assigned on May 27, 2008. Dr. Bander graduated from Harvard Medical School in 2004. Dr. Bander holds New York license 238699.

Dr. Bander's primary practice is Cardio Vascular Institute of Mount Sinai, at 432 Bedford Ave, Brooklyn, NY 11249 in Kings County. The practice phone is (212) 731-7822.

Dr. Bander's primary practice is Cardio Vascular Institute of Mount Sinai in Brooklyn, New York. Dr. Bander is also affiliated with Maimonides Medical Center. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Bander to 4 more hospitals, 3 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bander practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bander's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bander is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Bander is licensed in New York.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, congestive heart failure and coronary artery disease among the conditions Dr. Bander treats.

CMS data shows 3,314 Medicare services from Dr. Bander across 13 procedure codes in 2024, for 816 Medicare patients. Medicare paid $254,659 for them.

CMS counts 816 Medicare patients who saw Dr. Bander in 2024. The largest group is 65 to 74, with 378 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bander's median patient age at 63, with 43% women.

In 2024, Dr. Bander wrote 6,398 Medicare Part D claims for 687 patients. 79% of them were for generic drugs. CMS names the drug for 5,846 of them, across 81 drugs with 11 or more claims each, at $989,700 in total drug cost. In 2023, CMS named 5,247 claims across 71 drugs.

Dr. Bander accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bander as offering telehealth. CMS counts 20 procedures of coronary angioplasty and stenting by Dr. Bander, more than 50% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Bander, published from 2011 to 2022. 2020 was the busiest year, with 4. The most frequent topics are COVID-19, SARS-CoV-2 and Cardiovascular Diseases. Dr. Bander has published most often in PLoS One. Dr. Bander's most frequent co-authors are Usman Baber, MD, Annapoorna S. Kini, MD and Samin Sharma, MD.

CMS Open Payments shows 94 general payments to Dr. Bander from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $701.

Dmand AI lists 1 award for Dr. Bander.

Dr. Bander graduated from Harvard Medical School in 2004. Dr. Bander is a member of ACC.

Dr. Bander is in network with 17 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.